Intestinal absorption, organ distribution, and urinary excretion of the rare sugar D-psicose

Background The purpose of this study was to evaluate intestinal absorption, organ distribution, and urinary elimination of the rare sugar D-psicose, a 3-carbon stereoisomer of D-fructose that is currently being investigated and which has been found to be strongly effective against hyperglycemia and hyperlipidemia. Methods This study was performed using radioactive D-psicose, which was synthesized enzymatically from radioactive D-allose. Concentrations in whole blood, urine, and organs were measured at different time points until 2 hours after both oral and intravenous administrations and 7 days after a single oral administration (100 mg/kg body weight) to Wistar rats. Autoradiography was also performed by injecting 100 mg/kg body weight of 14C-labeled D-psicose or glucose intravenously to C3H mice. Results Following oral administration, D-psicose easily moved to blood. The maximum blood concentration (48.5±15.6 μg/g) was observed at 1 hour. Excretion to urine was 20% within 1 hour and 33% within 2 hours. Accumulation to organs was detected only in the liver. Following intravenous administration, blood concentration was decreased with the half-life=57 minutes, and the excretion to urine was up to almost 50% within 1 hour. Similarly to the results obtained with oral administration, accumulation to organs was detected only in the liver. Seven days after the single-dose oral administration, the remaining amounts in the whole body were less than 1%. Autoradiography of mice showed results similar to those in rats. High signals of 14C-labeled D-psicose were observed in liver, kidney, and bladder. Interestingly, no accumulation of D-psicose was observed in the brain. Conclusion D-psicose was absorbed well after oral administration and eliminated rapidly after both oral and intravenous administrations, with short duration of action. The study provides valuable pharmacokinetic data for further drug development of D-psicose. Because the findings were mainly based on animal study, it is necessary to implement human trials to study the metabolism pathway, which would give an important guide for human intake and food application of D-psicose.

[1]  Takako Yamada,et al.  d-Psicose increases energy expenditure and decreases body fat accumulation in rats fed a high-sucrose diet , 2014, International journal of food sciences and nutrition.

[2]  S. Swithers.  Artificial sweeteners produce the counterintuitive effect of inducing metabolic derangements , 2013, Trends in Endocrinology & Metabolism.

[3]  M. Ogawa,et al.  Transepithelial transports of rare sugar D-psicose in human intestine. , 2013, Journal of agricultural and food chemistry.

[4]  Takako Yamada,et al.  Reduction of abdominal fat accumulation in rats by 8-week ingestion of a newly developed sweetener made from high fructose corn syrup. , 2013, Food chemistry.

[5]  T. Matsunaga,et al.  Rare sugar D-psicose protects pancreas β-islets and thus improves insulin resistance in OLETF rats. , 2012, Biochemical and biophysical research communications.

[6]  Rachel K. Johnson,et al.  A Scientific Statement From the American Heart Association and the American Diabetes Association , 2012 .

[7]  Rachel K. Johnson,et al.  Nonnutritive Sweeteners: Current Use and Health Perspectives , 2012, Diabetes Care.

[8]  W. Mu,et al.  Recent advances on applications and biotechnological production of d-psicose , 2012, Applied Microbiology and Biotechnology.

[9]  T. Matsuo,et al.  The 90-day oral toxicity of d-psicose in male Wistar rats , 2011, Journal of clinical biochemistry and nutrition.

[10]  A. Nishiyama,et al.  Rare sugar D-psicose improves insulin sensitivity and glucose tolerance in type 2 diabetes Otsuka Long-Evans Tokushima Fatty (OLETF) rats. , 2011, Biochemical and biophysical research communications.

[11]  K. Adeli,et al.  Fructose: a highly lipogenic nutrient implicated in insulin resistance, hepatic steatosis, and the metabolic syndrome. , 2010, American journal of physiology. Endocrinology and metabolism.

[12]  Katsushi Tanaka,et al.  Crystal Structure, Solubility, and Mutarotation of the Rare Monosaccharide D-Psicose , 2010 .

[13]  Takako Yamada,et al.  Study on the Postprandial Blood Glucose Suppression Effect of D-Psicose in Borderline Diabetes and the Safety of Long-Term Ingestion by Normal Human Subjects , 2010, Bioscience, biotechnology, and biochemistry.

[14]  S. Baek,et al.  D-psicose, a sweet monosaccharide, ameliorate hyperglycemia, and dyslipidemia in C57BL/6J db/db mice. , 2010, Journal of food science.

[15]  T. Matsuo,et al.  The Study on Long-Term Toxicity of D-Psicose in Rats , 2009, Journal of clinical biochemistry and nutrition.

[16]  T. Matsuo,et al.  d-Psicose Inhibits Intestinal α-Glucosidase and Suppresses the Glycemic Response after Ingestion of Carbohydrates in Rats , 2009, Journal of clinical biochemistry and nutrition.

[17]  T. Matsuo,et al.  Acute D-psicose administration decreases the glycemic responses to an oral maltodextrin tolerance test in normal adults. , 2008, Journal of nutritional science and vitaminology.

[18]  M. Ogawa,et al.  Influence of a rare sugar, d-Psicose, on the physicochemical and functional properties of an aerated food system containing egg albumen. , 2008, Journal of agricultural and food chemistry.

[19]  M. Tokuda,et al.  Preventive effect of D-psicose, one of rare ketohexoses, on di-(2-ethylhexyl) phthalate (DEHP)-induced testicular injury in rat. , 2007, Toxicology letters.

[20]  K. Izumori,et al.  Psicose Contents in Various Food Products and its Origin , 2006 .

[21]  M. Tokuda,et al.  Large scale production of d-allose from d-psicose using continuous bioreactor and separation system , 2006 .

[22]  T. Matsuo,et al.  Effects of Dietary D‐Psicose on Diurnal Variation in Plasma Glucose and Insulin Concentrations of Rats , 2006, Bioscience, biotechnology, and biochemistry.

[23]  K. Izumori,et al.  Modification of ovalbumin with a rare ketohexose through the Maillard reaction: effect on protein structure and gel properties. , 2004, Journal of agricultural and food chemistry.

[24]  H. Maeta,et al.  Protective effects of D-allose against ischemia reperfusion injury of the rat liver. , 2003, Journal of hepato-biliary-pancreatic surgery.

[25]  T. Matsuo,et al.  D-psicose is a rare sugar that provides no energy to growing rats. , 2002, Journal of nutritional science and vitaminology.

[26]  T. Matsuo,et al.  Dietary D-psicose, a C-3 epimer of D-fructose, suppresses the activity of hepatic lipogenic enzymes in rats. , 2001, Asia Pacific journal of clinical nutrition.

[27]  P. Clifton,et al.  Short-chain fatty acids and human colonic function: roles of resistant starch and nonstarch polysaccharides. , 2001, Physiological reviews.

[28]  H. H. Rennhard,et al.  Caloric utilization and disposition of [14C]polydextrose in the rat. , 1981, Journal of agricultural and food chemistry.

[29]  R. Whistler,et al.  D-Psicose metabolism in the rat. , 1974, Carbohydrate Research.

[30]  W H Oldendorf,et al.  Brain uptake of radiolabeled amino acids, amines, and hexoses after arterial injection. , 1971, The American journal of physiology.

[31]  A. Perlin,et al.  O-isopropylidene derivatives of D-allulose (D-psicose) and D-erythro-hexopyranos-2,3-diulose. , 1968, Canadian journal of biochemistry.

[32]  G. Padberg.  Über die Kohlenhydrate im wäßrigen Eluat der menschlichen Hautoberfläche , 1967, Archiv für klinische und experimentelle Dermatologie.

[33]  G. Strecker,et al.  [THE KETOSES OF HUMAN URINE. IDENTIFICATION OF D (+)-ALLULOSE]. , 1965, Comptes rendus hebdomadaires des seances de l'Academie des sciences.

[34]  T. Swain,et al.  Chromatographic analyses of the free amino‐acids, organic acids and sugars in wheat plant extracts , 1960 .

[35]  M. Roizen.  Sugar-Sweetened Beverages and Risk of Metabolic Syndrome and Type 2 Diabetes: A meta-analysis , 2012 .

[36]  M. Tokuda,et al.  Izumoring: a novel and complete strategy for bioproduction of rare sugars. , 2004, Journal of bioscience and bioengineering.

[37]  T. Matsuo,et al.  Metabolic effects of D-psicose in rats: studies on faecal and urinary excretion and caecal fermentation. , 2003, Asia Pacific journal of clinical nutrition.

[38]  Yasuo Watanabe,et al.  A novel inhibitory effect of D-allose on production of reactive oxygen species from neutrophils. , 2003, Journal of bioscience and bioengineering.

[39]  K. Izumori,et al.  Mass production of D-psicose from d-fructose by a continuous bioreactor system using immobilized D-tagatose 3-epimerase. , 2000, Journal of bioscience and bioengineering.

[40]  G. Padberg.  [On the carbohydrates in the water eluate of the human skin surface]. , 1967, Archiv fur klinische und experimentelle Dermatologie.

[41]  L. Hough,et al.  Variation in the allitol content of Itea plants during photosynthesis , 1966 .